As President of the Pharma & Biopharma Outsourcing Association (PBOA), Gil leads the development and advancement of the association’s agenda across regulatory, legislative, and broader business sectors. His role includes engaging with member companies and industry stakeholders, negotiating with the FDA and other regulatory bodies, lobbying Congress, and collaborating with federal agencies. He also spearheads the creation of working groups, cross-industry initiatives, and partnerships with other trade associations. Throughout his tenure, [Last Name] has organized industry workshops and conferences, presented at FDA hearings and leading events, testified before Congressional subcommittees, conducted industry surveys, and coordinated panel discussions for trade shows. He has played a key role in building the PBOA brand by developing its website, producing its weekly newsletter, composing press releases, and recruiting dozens of new member companies. Under his leadership, PBOA has achieved several significant milestones, including the successful renegotiation of a multibillion-dollar user fee agreement that better serves the CMO/CDMO sector, the launch of the industry’s first conference exclusively for CDMOs and CMOs, and becoming a go-to resource for regulators seeking insight into the outsourcing space.